16,921 Shares in GE HealthCare Technologies Inc. $GEHC Bought by Sienna Gestion

Sienna Gestion acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, Holdings Channel.com reports. The firm acquired 16,921 shares of the company’s stock, valued at approximately $1,388,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Sofinnova Investments Inc. lifted its holdings in GE HealthCare Technologies by 6.5% during the fourth quarter. Sofinnova Investments Inc. now owns 160,876 shares of the company’s stock worth $13,195,000 after acquiring an additional 9,791 shares in the last quarter. USS Investment Management Ltd lifted its holdings in GE HealthCare Technologies by 8.6% during the fourth quarter. USS Investment Management Ltd now owns 91,164 shares of the company’s stock worth $7,479,000 after acquiring an additional 7,199 shares in the last quarter. Vanguard Personalized Indexing Management LLC lifted its holdings in GE HealthCare Technologies by 9.9% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 46,737 shares of the company’s stock worth $3,833,000 after acquiring an additional 4,204 shares in the last quarter. Sargent Investment Group LLC bought a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $292,000. Finally, MML Investors Services LLC lifted its holdings in shares of GE HealthCare Technologies by 5.4% in the fourth quarter. MML Investors Services LLC now owns 25,107 shares of the company’s stock valued at $2,059,000 after purchasing an additional 1,286 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently commented on GEHC shares. Evercore set a $80.00 price target on GE HealthCare Technologies in a report on Thursday, April 30th. BNP Paribas Exane lowered their target price on GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. Weiss Ratings downgraded GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 15th. Wells Fargo & Company lowered their target price on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research report on Thursday, April 30th. Finally, Piper Sandler lowered their target price on GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. Nine analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $80.21.

Insider Activity at GE HealthCare Technologies

In other news, CFO James Saccaro acquired 3,310 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 1st. The stock was bought at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the completion of the acquisition, the chief financial officer directly owned 87,471 shares in the company, valued at approximately $5,300,742.60. The trade was a 3.93% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Kevin Lobo acquired 10,000 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 22nd. The shares were purchased at an average price of $64.18 per share, with a total value of $641,800.00. Following the acquisition, the director owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last quarter, insiders have purchased 21,847 shares of company stock valued at $1,361,355. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Trading Down 0.6%

Shares of NASDAQ:GEHC opened at $64.76 on Tuesday. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The stock has a market cap of $29.46 billion, a PE ratio of 15.49, a P/E/G ratio of 1.47 and a beta of 0.74. The business has a 50 day moving average of $66.21 and a 200-day moving average of $75.07. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter in the prior year, the firm earned $1.01 EPS. The company’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.